Grade 3b Follicular Lymphoma

Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

2 drugs in development·1 company·2 clinical trials

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Grade 3b Follicular Lymphoma?

BioSniper tracks 2 drugs in development for Grade 3b Follicular Lymphoma across 1 company.

How many clinical trials target Grade 3b Follicular Lymphoma?

There are 2 clinical trials targeting Grade 3b Follicular Lymphoma tracked by BioSniper.

What is the prevalence of Grade 3b Follicular Lymphoma?

The estimated prevalence of Grade 3b Follicular Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Grade 3b Follicular Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Grade 3b Follicular Lymphoma — Drugs in Development & Clinical Trials | BioSniper